Medical management and evaluations of stable angina patients in tertiary care centre without invasive treatment
DOI:
https://doi.org/10.18203/2349-3933.ijam20173713Keywords:
2D-Echo, Aspirin, ECG, Coronary angiography, Stable anginaAbstract
Background: Ischemic heart disease is the important cause of morbidity and mortality in the community, it may present with wide variety of clinical entities. Chronic stable angina is a common condition and results in a considerable burden for both the individual and society. There are two approaches to the management of stable angina - percutaneous coronary intervention (PCI) and optimising medical therapy (OMT). Our study is focused on management of stable angina in tertiary care centre without invasive investigation.
Methods: This study carried out in Medicine Department, SIMS, Shimoga for 7 months from January 2017 to July 2017. 100 patients of chronic Stable Angina attending OPD of Mc Gann Hospital. A detailed history was taken in all the patients and a through physical examination was done. ECG, Blood investigations, 2D- Echocardiography and TMT is done.
Results: The mean age was (54.67±8.56) years. With male to female ratio being 1.2:1. ECG was normal in majority of patients (39%), followed by ST, T changes (33%), LVH (35%) and Hemiblock (36%). Hyperlipidemia (48%), Hypertension (42%) and Diabetes mellitus (37%) are major diseases associated with stable angina. Most of the patients are taking clopidogrel (96%) and aspirin (88%). Followed by ACE/ARB’s (70%) and statins (72%). Normal 2D-Echo is seen in 82% of cases. Diastolic dysfunction in 69%. Decreased ejection fraction in 23%. TMT is done in only 75 patients out of whom 9 could not complete the test. Inducible ischemia is positive in 48 patients.
Conclusions: Our study showed ECG changes, 2D Echo findings, TMT results and medication usage similar to other studies. However, there is less compliance with medication and risk factors are under controlled. Stable Angina is a common initial manifestation of coronary heart disease. It needs to be treated more aggressively to prevent complications. Increasing education regarding stable angina both among patients and physicians is need of the hour.
References
Lloyd-Jones D, Adams R, Carnethon M. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):e182.
Pflieger M. Medical management of stable coronary artery disease. American Family Physician 2011;83(7):819-26.
ESC guidelines on the management of stable coronary artery disease 2013. Eur Heart J. 2013;34:2949-3003.
Scottish Intercollegiate Guidelines Network. Guideline Management of stable angina; 2007:96.
Boden WE, O’Rourke RA, Teo KK. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-16.
RITA-2 Trial Participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet. 1997;350:461-8.
Griffin SC, Barber JA, Manca A. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ. 2007;334:624-7.
Stergiopoulos K. Initial coronary stent implantation with medical therapy versus medical therapy alone for stable coronary artery disease. Arch Intern Med. 2012;172:312-9.
Petty D. Optimising medical therapy for stable angina patients. Prim Care Cardiovasc J. 2015:1-5.
Campeau L. Grading of angina pectoris. Circulation. 1975;54:522-3.
Pahlajani D. Medical management and diagnostic testing among stable angina patients in India: The Stable angina observational (STAR) registry. J Asso Physic India. 2015;63:20-6.
Shital G, Gaurav P, Bijal P, Trivedi RS, Sharlin C. A study of left ventricular functionin cases of stable angina. Natl J Integr Res Med. 2017;8(1):41-3.
Koju R. Angiographic studies of coronary artery disease in dhulikhel hospital. Nepalese Heart. 2012;9(1):43-6.
Nesukay EG. Treatment of stable angina in Ukraine: CLASSICA study. Ukrainian J Cardiol. 2014;2:43-7.
Joaquín J. Prevalence of stable angina in spain: results of the OFRECE study. Rev Esp Cardiol. 2015;68:691-9.
Carasso S. Medical treatment of patients with stable angina pectoris referred for coronary angiography: failure of treatment or failure to treat. Clin Cardiol. 2002;25:436-41.
Daly C. Gender differences in the management and clinical outcome of stable angina. Circulation. 2006;113:490-8.
Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003.
Nieuwlaat R, Schwalm JD, Khatib R, Yusuf S. Why are we failing to implement effective therapies in cardiovascular disease? Eur Heart J. 2013;34:1262-9.
Yusuf S, Islam S, Chow CK. Prospective urban rural epidemiology study I. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the pure study): A prospective epidemiological survey. Lancet. 2011;378:1231-43.
